Yield of Combined Impedance-pH Monitoring for Refractory Reflux Symptoms in Clinical Practice

Overview

Journal J Neurogastroenterol Motil

Date 2011 May 24

PMID 21602992

Citations 15

Authors

Georgios Karamanolis

Georgios Kotsalidis

Konstantinos Triantafyllou

Dimitrios Polymeros

Asimina Gaglia

Smaragdi Fessatou

Maria Triantafyllou

Ioannis Papanikolaou

Spiros D Ladas

Affiliations

Soon will be listed here.

Abstract

Background/aims: In patients with gastroesophageal reflux disease, persistent symptoms on proton pump inhibitor (PPI) therapy may be due to residual acid or non-acid reflux. Combined impedance-pH has been suggested to be superior to pH alone in the management of refractory patients to PPI. The utility of implementation of this technique in every day clinical practice is still unknown. The aim of this study was to investigate the outcomes of patients studied with combined impedance-pH and to evaluate the yield of additional impedance monitoring over pH alone in patients with persistent gastroesophageal reflux disease symptoms.

Methods: Seventy-one patients (31 men; mean age, 49.1 ± 15.5 years) on PPI therapy underwent combined impedance-pH for persistent typical (76%) or atypical (49%) symptoms.

Results: During impedance-pH study, 44 (62%) patients reported symptoms. A positive symptom index (SI) was found in 21 (48%) patients: 8 (18.2%) had a positive SI for acid reflux, 9 (20.5%) for non-acid reflux and 4 (9.1%) for mixed reflux. Addition of impedance allowed association between reflux and symptoms in 20.5% of patients who would have been missed by pH study alone. Heartburn was the most prevalent symptom associated with acid reflux, whereas regurgitation and ear, nose and throat symptoms were associated with non-acid reflux.

Conclusions: The use of combined impedance-pH monitoring substantially increased the diagnostic yield compared to pH alone. With SI analysis, 20.5% of patients received a diagnosis that could not have been achieved with pH testing alone.

Citing Articles

Reflux definitions in esophageal multi-channel intraluminal impedance.

Rasouli A, Soheilipour M, Raisi M, Rabbani H, Eghbalifard N, Adibi P Gastroenterol Hepatol Bed Bench. 2024; 16(4):408-414.

PMID: 38313352 PMC: 10835088. DOI: 10.22037/ghfbb.v16i4.2776.

Latin American consensus on diagnosis of gastroesophageal reflux disease.

Olmos J, Pandolfino J, Piskorz M, Zamora N, Valdovinos Diaz M, Remes Troche J Neurogastroenterol Motil. 2024; 36(3):e14735.

PMID: 38225792 PMC: 11720354. DOI: 10.1111/nmo.14735.

Extended Wireless pH Monitoring Significantly Increases Gastroesophageal Reflux Disease Diagnoses in Patients With a Normal pH Impedance Study.

Zeki S, Miah I, Visaggi P, Wolak A, deSilva M, Dunn J J Neurogastroenterol Motil. 2023; 29(3):335-342.

PMID: 37417260 PMC: 10334198. DOI: 10.5056/jnm22130.

Breathing Exercises in Gastroesophageal Reflux Disease: A Systematic Review.

Zdrhova L, Bitnar P, Balihar K, Kolar P, Madle K, Martinek M Dysphagia. 2022; 38(2):609-621.

PMID: 35842548 PMC: 9888515. DOI: 10.1007/s00455-022-10494-6.

Multichannel Intraluminal Impedance and pH Monitoring are Complementary Methods in the Diagnosis of Gastroesophageal Reflux Disease in Children.

Altay D, Ozkan T, Ozgur T, Sahin N Eurasian J Med. 2022; 54(1):22-26.

PMID: 35307624 PMC: 9634897. DOI: 10.5152/eurasianjmed.2022.20265.

References

Charbel S, Khandwala F, Vaezi M . The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol. 2005; 100(2):283-9. DOI: 10.1111/j.1572-0241.2005.41210.x. View

Bredenoord A, Weusten B, Smout A . Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut. 2005; 54(12):1810-7. PMC: 1774780. DOI: 10.1136/gut.2005.072629. View

Joniau S, Bradshaw A, Esterman A, Carney A . Reflux and laryngitis: a systematic review. Otolaryngol Head Neck Surg. 2007; 136(5):686-92. DOI: 10.1016/j.otohns.2006.12.004. View

Klinkenberg-Knol E, Festen H, Jansen J, Lamers C, Nelis F, Snel P . Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med. 1994; 121(3):161-7. DOI: 10.7326/0003-4819-121-3-199408010-00001. View

Zerbib F, Roman S, Ropert A, Bruley des Varannes S, Pouderoux P, Chaput U . Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol. 2006; 101(9):1956-63. DOI: 10.1111/j.1572-0241.2006.00711.x. View

Xue S, Katz P, Banerjee P, Tutuian R, Castell D . Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther. 2001; 15(9):1351-6. DOI: 10.1046/j.1365-2036.2001.01050.x. View

Lam H, Breumelhof R, Roelofs J, van Berge Henegouwen G, Smout A . What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data?. Dig Dis Sci. 1994; 39(2):402-9. DOI: 10.1007/BF02090215. View

Dean B, Gano Jr A, Knight K, Ofman J, Fass R . Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2004; 2(8):656-64. DOI: 10.1016/s1542-3565(04)00288-5. View

Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D . Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006; 55(10):1398-402. PMC: 1856433. DOI: 10.1136/gut.2005.087668. View

10.

Sharma N, Agrawal A, Freeman J, Vela M, Castell D . An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol. 2008; 6(5):521-4. DOI: 10.1016/j.cgh.2008.01.006. View

11.

Bredenoord A, Weusten B, Timmer R, Smout A . Minimum sample frequency for multichannel intraluminal impedance measurement of the oesophagus. Neurogastroenterol Motil. 2004; 16(6):713-9. DOI: 10.1111/j.1365-2982.2004.00575.x. View

12.

Kahrilas P, Shaheen N, Vaezi M . American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008; 135(4):1392-1413, 1413.e1-5. DOI: 10.1053/j.gastro.2008.08.044. View

13.

Vela M, Srinivasan R, Tutuian R, Katz P, Castell D . Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001; 120(7):1599-606. DOI: 10.1053/gast.2001.24840. View

14.

Leite L, Johnston B, Just R, Castell D . Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol. 1996; 91(8):1527-31. View

15.

Blonski W, Vela M, Castell D . Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy. J Clin Gastroenterol. 2009; 43(9):816-20. DOI: 10.1097/MCG.0b013e318194592b. View

16.

DeVault K, Castell D . Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005; 100(1):190-200. DOI: 10.1111/j.1572-0241.2005.41217.x. View

17.

Sontag S, Hirschowitz B, Holt S, Robinson M, Behar J, Berenson M . Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study. Gastroenterology. 1992; 102(1):109-18. DOI: 10.1016/0016-5085(92)91790-b. View

18.

Nebel O, Fornes M, Castell D . Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976; 21(11):953-6. DOI: 10.1007/BF01071906. View

19.

Kline M, Ewing M, Simpson N, Laine L . The utility of intraluminal impedance in patients with gastroesophageal reflux disease-like symptoms but normal endoscopy and 24-hour pH testing. Clin Gastroenterol Hepatol. 2008; 6(8):880-5. DOI: 10.1016/j.cgh.2008.01.016. View

20.

Isolauri J, Laippala P . Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med. 1995; 27(1):67-70. DOI: 10.3109/07853899509031939. View